Viewing Study NCT05872295

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:21 PM
Ignite Modification Date: 2026-01-01 @ 6:45 AM
Study NCT ID: NCT05872295
Status: RECRUITING
Last Update Posted: 2025-09-30
First Post: 2023-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: IKS014 in Advanced Solid Tumors That Express HER2
Sponsor: Iksuda Therapeutics Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Gastric Cancer View
None Gastroesophageal-junction Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2 View
None IKS014 View
None Low HER2 View
None Advanced tumors View
None HER2+ View
None HER2-positive View
None HER2 expression View
None GEJ View